What is Dharmik Patel's NPI number?

Dharmik Patel's National Provider Identifier (NPI) is 1316408081, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Dharmik Patel's specialty?

Dharmik Patel is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Dharmik Patel located?

Dharmik Patel's practice location on file with NPPES is 560 S Maple St Ste 400, Waconia, MN 55387-1757.

What is Dharmik Patel's phone number?

The practice phone number listed in the NPPES registry for Dharmik Patel is (952) 442-3188.

Does Dharmik Patel accept Medicare?

Dharmik Patel is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Dharmik Patel's NPI active?

Yes — Dharmik Patel's NPI (1316408081) is active in the NPPES registry as of the last update on 2025-09-03.

IndividualActiveAccepts Medicare

Dharmik Patel, MD

NPI 1316408081 · Dermatology Physician · Waconia, MN

Dharmik Patel, MD is a Dermatology Physician provider in Waconia, MN (NPI 1316408081).

Provider details

NPI number: 1316408081
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Male
Sole proprietor: No
License: 78689 (MN)

Practice location

560 S Maple St Ste 400

Waconia, MN 55387-1757

Phone: (952) 442-3188

Fax: (952) 442-7861

Street-level locationGet directions

More MN providers

Mailing address

560 S Maple St Ste 400

Waconia, MN 55387-1757

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 78689 (MN)
Allopathic & Osteopathic Physicians

Additional practice locations (1)

675 Water St
Excelsior, MN 55331-3158
Phone: (952) 442-3188

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(62/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
7 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
2 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
1,712 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	458	$6
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	290	$120
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	258	$85
Destruction of Precancer Skin Growth, 1 Growth17000	184	$47
Destruction of Skin Growth, 1-14 Growths17110	173	$103
Biopsy of Related Skin Growth, First Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 17 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	194	134
Clobetasol Propionate	149	99
Ketoconazole	127	83
Doxycycline Monohydrate	87	68
Mupirocin	84	67
Spironolactone	36	15
Minoxidil	32	—
Metronidazole	26

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$3,147 across 173 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2019-03-26
Last updated: 2025-09-03
Certified: 2025-09-03

Frequently asked questions

What is Dharmik Patel's NPI number?: Dharmik Patel's National Provider Identifier (NPI) is 1316408081, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Dharmik Patel's specialty?: Dharmik Patel is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Dharmik Patel located?: Dharmik Patel's practice location on file with NPPES is 560 S Maple St Ste 400, Waconia, MN 55387-1757.
What is Dharmik Patel's phone number?: The practice phone number listed in the NPPES registry for Dharmik Patel is (952) 442-3188.
Does Dharmik Patel accept Medicare?: Dharmik Patel is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Dharmik Patel's NPI active?: Yes — Dharmik Patel's NPI (1316408081) is active in the NPPES registry as of the last update on 2025-09-03.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	458	$6
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	290	$120
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	258	$85
Destruction of Precancer Skin Growth, 1 Growth17000	184	$47
Destruction of Skin Growth, 1-14 Growths17110	173	$103
Biopsy of Related Skin Growth, First Growth

Drug

Part D claims (2024)

Beneficiaries

Triamcinolone Acetonide

194

134

Clobetasol Propionate

149

Ketoconazole

127

Doxycycline Monohydrate

Mupirocin

Spironolactone

Minoxidil

—

Metronidazole

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$3,147 across 173 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (1)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (1)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments